surpass-2 tirzepatide vs semaglutide weight loss SURPASS-2- in Type 2 Diabetes Semaglutide. Tirzepatide. Retatrutide. Same goal

Having a transition plan to alternative medications or brand-name tirzepatide is prudent regardless of your current access situation

Of 248 patients diagnosed with rhabdomyolysis, seizures (31.9%), illicit drug use or alcohol (9.7%), and exercise (8.5%) were the most common triggers

Ozempic (semaglutide) : approved for type 2 diabetes Wegovy (semaglutide) : approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with weight-related comorbidities Mounjaro (tirzepatide) : approved for type 2 diabetes Zepbound (tirzepatide) : approved for chronic weight management under the same criteria as Wegovy If you dont have diabetes, the weight-management brands (Wegovy, Zepbound) are what your doctor would prescribe, assuming you meet the criteria

A research article on evaluating the impact of tirepatide with nutrition and physical activity to maintain weight reduction

The side effect comparison between the two medications further clarifies what to expect during and after the switch

Is compounded oral tirzepatide FDA approved